文章摘要
来洁,王安妮,朱梦洁,等.消瘀泄浊饮对慢性肾脏病2~4期患者Th17/Treg细胞免疫平衡的影响[J].浙江中医药大学学报,2021,45(7):761-764, 791.
消瘀泄浊饮对慢性肾脏病2~4期患者Th17/Treg细胞免疫平衡的影响
The Effect of Xiaoyu Xiezhuo Decoction on Th17/Treg Cell Immune Balance in Patients with Chronic Kidney Disease Stage 2~4
DOI:10.16466/j.issn1005-5509.2021.07.014
中文关键词: 消瘀泄浊饮  慢性肾脏病  气虚夹瘀  Th17细胞  Treg细胞,CD+4T细胞  免疫平衡  24h尿蛋白定量
英文关键词: Xiaoyu Xiezhuo Decoction  chronic kidney disease  Qi deficiency and blood stasis  Th17  Treg  CD+4T  immune balance  24 hour urinary protein quantity
基金项目:浙江省自然科学基金项目(LY16H270007)
作者单位E-mail
来洁 杭州市萧山区中医院 杭州 311201  
王安妮 杭州市中医院丁桥院区  
朱梦洁 浙江绿城心血管病医院  
夏璁 浙江中医药大学附属第一医院  
鲁科达 浙江中医药大学附属第一医院  
何灵芝 浙江中医药大学附属第一医院 kid_doc@126.com 
摘要点击次数: 1679
全文下载次数: 601
中文摘要:
      [目的]观察消瘀泄浊饮对慢性肾脏病(chronic kidney disease,CKD)2~4期患者辅助性T细胞17(T helper cell 17,Th17)/调节性T细胞(regulatory cells,Treg)免疫平衡的影响。[方法]选取CKD 2~4期气虚夹瘀型患者共80例,随机分为两组:对照组40例,仅予基础治疗;治疗组40例,除基础治疗外加用中药汤剂消瘀泄浊饮治疗,1剂/d,分早晚两次服用。治疗12周后,比较两组治疗前后外周血Th17、Treg细胞占CD+4T细胞的比例和相关指标变化情况,对比总结其临床疗效。[结果]治疗组治疗后,Th17、血肌酐(serum creatinine,Scr)、血尿素氮(blood urea nitrogen,BUN)、24h尿蛋白定量(24 hour urinary protein quantity,24UPr)水平较治疗前明显下降(P<0.01),血低密度脂蛋白胆固醇(low density lipoprotein cholesterin,LDL-C)水平较治疗前下降(P<0.05),白蛋白(albumin,ALB)水平较治疗前明显升高(P<0.01),Treg水平较治疗前升高(P<0.05)。治疗后治疗组Th17、Scr、BUN水平低于对照组(P<0.05)。治疗组总体疗效评价中总有效率42.5%,明显高于对照组(P<0.01)。[结论]消瘀泄浊饮配合复方α-酮酸片等基础治疗,能够提高CKD 2~4期气虚夹瘀型患者Treg细胞水平,降低Th17细胞水平,恢复Th17/Treg免疫平衡状态,同时能够改善肾功能,延缓CKD病情进展。
英文摘要:
      [Objective] To observe the effect of Xiaoyu Xiezhuo Decoction on T helper cell 17(Th17)/regulatory cells(Treg) cell immune balance in patients with chronic kidney disease(CKD) in stage 2~4.[Methods] A total of 80 patients with CKD stage 2~4 Qi deficiency and blood stasis syndrome were selected and randomly divided into two groups: 40 cases in control group, the patients were only given basic treatment; 40 cases in treatment group were treated with Xiaoyu Xiezhuo Decoction in addition to basic treatment, 1 dose per day, once in the morning and once in the evening. After 12 weeks of treatment, the ratio of Th17 and Treg cells in peripheral blood to CD+4 T cells and changes in related indicators were compared between the two groups before and after treatment, and the clinical efficacy was compared.[Results] After treatment, the levels of Th17,serum creatinine(Scr), blood urea nitrogen(BUN) and 24 hour urinary protein quantity(24UPr) in treatment group were significantly lower than before treatment(P<0.01), the level of low density lipoprotein cholesterin(LDL-C) was lower than before treatment(P<0.05), and the level of albumin(ALB) was significantly higher than before treatment(P<0.01),the level of Treg was higher than before treatment(P<0.05). After treatment, the ratio of Th17, and the levels of Scr and BUN in treatment group were lower than those in control group(P<0.05). The total effective rate of treatment group was 42.5%, significantly higher than that of control group(P<0.01).[Conclusion] Xiaoyu Xiezhuo Decoction combined with compound α-ketoacid tablets and other basic treatment of patients with CKD stage 2~4 Qi deficiency and blood stasis syndrome can increase the level of Treg cells, reduce the level of Th17 cells, and restore the immune imbalance of Th17/Treg, and protect the kidney function, delay the progress of CKD.
查看全文   查看/发表评论  下载PDF阅读器
关闭